Dimerix Limited a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from Mission Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results